Alpine Global Management, LLC Xeris Biopharma Holdings, Inc. Transaction History
Alpine Global Management, LLC
- $280 Million
- Q2 2025
A detailed history of Alpine Global Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Alpine Global Management, LLC holds 150,000 shares of XERS stock, worth $1.39 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
150,000
Previous 100,000
50.0%
Holding current value
$1.39 Million
Previous $549,000
27.5%
% of portfolio
0.25%
Previous 0.21%
Shares
17 transactions
Others Institutions Holding XERS
# of Institutions
214Shares Held
90.1MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$90.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.26B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...